Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
- Resource Type
- Article
- Authors
- Maher, Toby M ; Corte, Tamera J; Fischer, Aryeh; Kreuter, Michael; Lederer, David J; Molina-Molina, Maria; Axmann, Judit; Kirchgaessler, Klaus-Uwe; Samara, Katerina; Gilberg, Frank; Cottin, Vincent
- Source
- In The Lancet Respiratory Medicine February 2020 8(2):147-157
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600